Form 4 for KPTI Karyopharm Therapeutics Inc.
Accepted 2023-04-24 00:00:00 ET · period of report 2023-04-20 · accession 0001209191-23-025464 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-04-24 | 2023-04-20 | KPTI | Rangwala Reshma | EVP, Chief Medical Off | S - Sale | $4.05 | -6,770 | 158.2K | -4% | -$27.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-20 | S | D | 115 | $4.03 | 164,885 | D | — | — | |
| 2 | Common | Common Stock | 2023-04-20 | S | D | 6,655 | $4.05 | 158,230 | D | — | — |